BPC-157 Research: Complete Guide
Target keywords: BPC-157 research, BPC-157 studies, BPC-157 peptide, gastric pentadecapeptide Word count: 3,000+ Internal links: bpc-157 product, bpc-157-dosage-protocol, bpc-157-mechanism-action, bpc-157-vs-tb-500-comparison
Introduction
BPC-157 (Body Protection Compound-157) is one of the most extensively studied synthetic peptides in preclinical research. Derived from a 15-amino-acid sequence found in human gastric juice, this pentadecapeptide has attracted significant scientific attention for its broad-spectrum tissue repair properties.
This guide provides a comprehensive overview of BPC-157 research, covering its chemical properties, mechanisms of action, research applications, and quality considerations for laboratory use.
Chemical Properties
| Property | Value |
|---|---|
| Sequence | GEPPPGKPADDAGLV |
| Molecular Weight | 1,419.53 g/mol |
| Amino Acids | 15 |
| Solubility | Aqueous (high) |
| Purity (research grade) | >= 98% HPLC |
| Storage (lyophilised) | -20C |
| Storage (reconstituted) | 2-8C, use within 30 days |
BPC-157 is notable for its stability in both aqueous and acidic conditions — a property inherited from its gastric juice origin. This stability contributes to its oral bioavailability in animal models, which is unusual for peptides of this size.
Mechanism of Action
BPC-157 exerts its effects through multiple pathways:
Nitric Oxide System
BPC-157 modulates the nitric oxide (NO) system, which plays a central role in vasodilation, angiogenesis, and tissue repair. Research demonstrates that BPC-157 upregulates eNOS (endothelial nitric oxide synthase) expression, promoting blood vessel formation in damaged tissue.
Growth Factor Modulation
Studies indicate BPC-157 influences the expression of several growth factors:
- VEGF (Vascular Endothelial Growth Factor) — promotes angiogenesis
- FGF (Fibroblast Growth Factor) — supports cell proliferation
- TGF-beta (Transforming Growth Factor-beta) — regulates tissue remodelling
- EGF (Epidermal Growth Factor) — supports epithelial cell growth
Actin Polymerisation
BPC-157 has been shown to influence actin polymerisation, the process by which cells migrate and reorganise their cytoskeleton. This is particularly relevant for wound healing, where cell migration to the injury site is a critical early step.
Gastrointestinal Protection
The peptide's gastric origin gives it particular relevance in GI research. Studies in animal models have demonstrated protective effects on the stomach lining, intestinal anastomosis healing, and liver protection.
Research Applications
Wound Healing
The most extensively studied application of BPC-157 is wound healing. Preclinical models demonstrate:
- Accelerated closure of full-thickness wounds
- Enhanced collagen deposition and organisation
- Improved angiogenesis in wound tissue
- Reduced scar formation
Tendon and Ligament Repair
Research in animal models shows BPC-157 promotes healing of:
- Achilles tendon injuries
- Ligament ruptures
- Muscle crush injuries
- Bone fracture repair
Gastrointestinal Protection
BPC-157 has been studied for:
- Gastric ulcer protection
- Intestinal anastomosis healing
- Liver protection from toxic agents
- Pancreatic protection
Neuroprotection
Emerging research explores BPC-157's effects on:
- Peripheral nerve regeneration
- Spinal cord injury models
- Cerebrovascular protection
Organ Protection
Preclinical studies demonstrate protective effects on:
- Liver (from alcohol and toxin-induced damage)
- Heart (ischaemia-reperfusion injury)
- Kidney (nephrotoxicity models)
Dosage and Administration in Research
Research dosages vary by model and route of administration:
| Route | Typical Range | Notes |
|---|---|---|
| Intraperitoneal | 1-10 mcg/kg | Most common in animal studies |
| Oral | 10-100 mcg/kg | Effective due to GI stability |
| Topical | 1-5 mcg/kg | Applied directly to wound site |
Reconstitution: BPC-157 dissolves readily in bacteriostatic water. No special solvents required. See our Reconstitution Guide for detailed protocols.
Quality Considerations
When sourcing BPC-157 for research, verify:
- HPLC Purity: Minimum 98%, verified by independent HPLC analysis
- Mass Spectrometry: Identity confirmation matching expected molecular weight
- Certificate of Analysis: Batch-specific documentation with analytical data
- Storage Conditions: Proper cold-chain management during shipping
Buy BPC-157 Research Peptide — 98%+ HPLC purity, COA included with every batch.
Related Research
- BPC-157 Dosage Protocol — Detailed administration guide
- BPC-157 Mechanism of Action — Deep-dive into cellular pathways
- BPC-157 vs TB-500 — Comparison with Thymosin Beta-4 fragment
- Best Peptides for Tissue Repair — Comparison of repair peptides
References
- Sikiric P, et al. "Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract." Current Pharmaceutical Design. 2011.
- Chang CH, et al. "BPC-157 accelerates tendon healing." Journal of Surgical Research. 2011.
- Staresinic M, et al. "Effect of BPC-157 on tendon healing." Journal of Orthopaedic Research. 2003.
- Boban Blagaic A, et al. "BPC-157 and wound healing." Wound Repair and Regeneration. 2009.
Meta title: BPC-157 Research: Complete Guide to Studies, Mechanisms, and Applications | Kingston Peptides Meta description: Comprehensive guide to BPC-157 (gastric pentadecapeptide) research. Covers chemical properties, mechanisms of action, wound healing, GI protection, and quality considerations for laboratory use.